OTCMKTS:FSNUY Fresenius SE & Co. KGaA (FSNUY) Stock Price, News & Analysis $9.21 -0.21 (-2.23%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$9.21▼$9.3050-Day Range$7.70▼$9.4252-Week Range$6.33▼$9.50Volume12,208 shsAverage Volume52,971 shsMarket Capitalization$20.58 billionP/E Ratio12.49Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendEarningsHeadlinesShort InterestStock AnalysisChartDividendEarningsHeadlinesShort Interest Get Fresenius SE & Co. KGaA alerts: Email Address Ad Porter & CompanyWhy billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. Click here for my exclusive video About Fresenius SE & Co. KGaA Stock (OTCMKTS:FSNUY)Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.Read More FSNUY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FSNUY Stock News HeadlinesSeptember 2, 2024 | markets.businessinsider.comFresenius Sells IV Manufacturing Site In Chile To Medifarma; Terms Not DisclosedSeptember 1, 2024 | finance.yahoo.comFresenius Kabi and AABB Announce Start of 19th Annual Blood Collectors Week September 1-7, 2024September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 24, 2024 | uk.finance.yahoo.comJinxin Fertility Group Limited (JXFGF)July 31, 2024 | seekingalpha.comFresenius SE & Co. KGaA (FSNUF) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | bloomberg.comFresenius Beats Views on Spain Hospital Services, Cost CutsJuly 31, 2024 | markets.businessinsider.comFresenius Q2 Adj. Profit Rises, Organic Revenue Growth At 8%; Confirms FY24 OutlookJuly 30, 2024 | msn.comFresenius Medical’s US Business Remains Sluggish, Hits SalesSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.July 20, 2024 | finance.yahoo.comFresenius SE & Co. KGaA (1FRE.MI)May 8, 2024 | msn.comFresenius Lifts Guidance On Net Profit BeatMay 8, 2024 | nasdaq.comFresenius Raises FY24 OutlookMay 7, 2024 | bloomberg.comFresenius Boosts Forecast, Confirms Plans to Exit Vamed BusinessMay 7, 2024 | markets.businessinsider.comEQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024May 1, 2024 | msn.comCVS Health Non-GAAP EPS of $1.31 misses by $0.39, revenue of $88.4B misses by $800MApril 19, 2024 | wsj.comFresenius SE & Co. KGaA ADRApril 16, 2024 | finance.yahoo.comUPDATE 1-STOXX 600 nears six-week low on geopolitical jitters; Ericsson shinesApril 4, 2024 | finance.yahoo.comIs Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?See More Headlines Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/31/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolOTCMKTS:FSNUY CUSIPN/A CIKN/A Webwww.fresenius.com Phone(496) 172-6080FaxN/AEmployees316,920Year Founded1912Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio12.49 Forward P/E Ratio11.23 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$24.01 billion Price / Sales0.86 Cash Flow$2.18 per share Price / Cash Flow4.23 Book Value$15.07 per share Price / Book0.61Miscellaneous Outstanding Shares2,234,009,000Free FloatN/AMarket Cap$20.58 billion OptionableNot Optionable Beta1.05 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Michael Sen (Age 56)CEO, President & Chairman of Management Board - Fresenius Management SE Comp: $4.44MMs. Sara Lisa Hennicken (Age 44)CFO & Member of the Management Board - Fresenius Management SE Comp: $1.68MMr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius KabiDr. Michael Sven Moser Ph.D. (Age 46)Member of Management Board of Fresenius Management SE Comp: $1.3MMr. Robert Moller (Age 53)Member of the Management Board of Fresenius Management SE Comp: $1.25MMr. Markus GeorgiSenior Vice President of Investor RelationsMatthias LinkSenior Vice President Corporate CommunicationsMore ExecutivesKey CompetitorsLuxottica GroupOTCMKTS:LUXTYZimmer BiometNYSE:ZBHSmith & NephewNYSE:SNNSolventumNYSE:SOLVPenumbraNYSE:PENView All Competitors FSNUY Stock Analysis - Frequently Asked Questions How have FSNUY shares performed this year? Fresenius SE & Co. KGaA's stock was trading at $7.7250 on January 1st, 2024. Since then, FSNUY shares have increased by 19.2% and is now trading at $9.21. View the best growth stocks for 2024 here. How were Fresenius SE & Co. KGaA's earnings last quarter? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its earnings results on Wednesday, July, 31st. The company reported $0.22 earnings per share for the quarter. The firm earned $5.83 billion during the quarter. How do I buy shares of Fresenius SE & Co. KGaA? Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FSNUY) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius SE & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
